Current Status on 1,4-Dihydropyridine Derivatives against Human Pathogenic Parasites

Abstract

Infections provoked by parasites are among the most prevalent diseases worldwide and generate important health and socioeconomic problems. Despite the enormous amount of work done, the chemotherapy for most of them remains unsolved. Usually, treatments are based on no specific drugs associated, in several cases, with long-term treatments and severe side effects. In addition, drug resistance and different strains' susceptibility are further drawbacks of the existing chemotherapy. Considering that 1,4-dihy-dropyridines derivatives constitute an important class of compounds for new drug devel-opment, we present in this review an in-depth overview of the work done so far on 1,4-di-hydropyridines and their antiparasitic activities. The development of new derivatives or the application of known drugs used for other diseases is described in terms of their potential usefulness for drug design.